Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy by Oscar Ardenfors, Joachim N. Nilsson, Daniel Thor, Cecilia Hindorf

Get full text

Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism by Joachim N. Nilsson, Rebecca Elovsson, Daniel Thor, Jan Calissendorff, Oscar Ardenfors

Get full text

Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy by Märta Persson, Cecilia Hindorf, Oscar Ardenfors, Martin Larsson, Joachim N. Nilsson

Get full text

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki... by Joachim N. Nilsson, Jonathan Siikanen, Christel Hedman, C. Christofer Juhlin, Catharina Ihre Lundgren

Get full text

Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up by Joachim N Nilsson, Jonathan Siikanen, Vincenzo Condello, Kenbugul Jatta, Ravi Saini, Christel Hedman, Catharina Ihre Lundgren, C Christofer Juhlin

Get full text

Comparative in vivo biodistribution of cells labelled with [89Zr]Zr-(oxinate)4 or [89Zr]Zr-DFO-NCS using PET by Ida Friberger, Joachim N. Nilsson, Li Lu, Jonathan Siikanen, Oscar Ardenfors, Stefan Milton, Erik Samén, Jeroen A. C. M. Goos, Mattias Carlsten, Staffan Holmin, Thuy A. Tran

Get full text